Novo Nordisk Is Losing Its Lead To Eli Lilly In The Obesity Drug War. Here’s What Went Wrong.
On this episode of Growth Stories, we take a look at the escalating rivalry between Novo Nordisk and Eli Lilly and how the Danish drugmaker lost its grip on the weight-loss drug market.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
19:19
--------
19:19
Nano Nuclear Energy Has Surged 650% Since Its Public Debut. CEO Says Growth Is Just Getting Started.
On this episode of Growth Stories, we talk to Nano Nuclear Energy CEO James Walker to learn about the company's quest to bring portable nuclear power to market.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
20:12
--------
20:12
Netflix's Trillion-Dollar Quest: Inside The Streamer's Bold Bet On Future Growth
Wall Street's most exclusive club consists of companies with market caps over a trillion dollars. And Netflix wants to add its name to that list. On this episode of Growth Stories, we take a look at the company's bold growth goals and explore whether the streaming titan is poised for a blockbuster performance or disappointing fizzle.
Learn more about your ad choices. Visit megaphone.fm/adchoices
--------
16:42
--------
16:42
Trump's China Deal Catapults Rare Earths Into Global Focus
A new trade agreement with China is catapulting a group of organic heavy metals into the spotlight. On this episode of Growth Stories, we delve into the world of rare earths and explore how recent trade talks have brought this often-overlooked market into global focus.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Growth Stories is a podcast about the innovations and trends driving the stock market’s next big winners. IBD multimedia reporter Alexis Garcia interviews analysts, executives, authors and influencers to take investors behind the latest innovations and trends driving growth in leading companies and sectors.
Colombia